Saleeby, E.; Bielinski, K.; Fitzgerald, A.; Siegel, J.; Ibrahim, S. A Prospective, Multi-Center Clinical Utility Study Demonstrates That the 40-Gene Expression Profile (40-GEP) Test Impacts Clinical Management for Medicare-Eligible Patients With High-Risk Cutaneous Squamous Cell Carcinoma (cSCC). J of Skin 2022, 6, 482-496.